Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 7 publications
mTORC1 Inhibitor Rapamycin Inhibits Growth of Cerebral Cavernous Malformation in Adult Mice.
Journal: Stroke
Published: September 25, 2023
Sinusoidal and lymphatic vessel growth is controlled by reciprocal VEGF-C-CDH5 inhibition.
Journal: Nature cardiovascular research
Published: March 13, 2023
Developmental venous anomalies are a genetic primer for cerebral cavernous malformations.
Journal: Nature cardiovascular research
Published: March 31, 2022
Cerebral Cavernous Malformation: From Mechanism to Therapy.
Journal: Circulation research
Published: June 24, 2021
PIK3CA and CCM mutations fuel cavernomas through a cancer-like mechanism.
Journal: Nature
Published: August 25, 2020
Cerebral cavernous malformations are driven by ADAMTS5 proteolysis of versican.
Journal: The Journal of experimental medicine
Published: January 27, 2020
Distinct cellular roles for PDCD10 define a gut-brain axis in cerebral cavernous malformation.
Journal: Science translational medicine
Published: December 14, 2018
Showing 1-7 of 7
Last Updated: 09/26/2026